Lobular carcinoma is a type of breast cancer that affects the milk gland area and accounts for 10% of all breast cancer cases. There are two types: invasive and in situ. Invasive lobular carcinoma often tests positive for hormone receptors and has a better prognosis than other invasive breast cancers. Lobular carcinoma in situ is a precancerous condition that increases the risk of developing invasive breast cancer later on. Treatment depends on each individual situation. Regular breast checks increase the chance of detecting cancer in its early stages.
Lobular carcinoma is a type of breast cancer that attacks the lobular, or milk gland, area of the breast. Lobular carcinoma is the second most common type of breast cancer. It accounts for about 10% of all breast cancer cases. There are two different types of lobular carcinoma.
Invasive lobular carcinoma (ILC) begins in the milk glands of the breast and eventually spreads to surrounding tissue. It does not normally show up on a mammogram, however, it appears to have a better prognosis than other invasive breast cancers. Breast cancer tends to grow in the last part of the lobule glands. The tumor may look like a thickening in the upper outer part of the breast and can be found when a woman does a breast self-examination.
The skin may wrinkle in the area where the tumor is located. Invasive lobular carcinoma often tests positive for estrogen or progesterone receptors and usually responds well to hormone treatments. If not caught early on and treated, this type of cancer can eventually spread to the woman’s ovaries and uterus.
Lobular carcinoma in situ (LCIS) is a form of pre-invasive breast cancer and is often considered a precancerous condition of the breast. Abnormal cells have been discovered, however, this particular diagnosis means that it was discovered before the breast was invaded by cancer cells. During this stage the cancer cells have the ability to multiply but have not moved beyond the lining of the lobule and into other areas of the breast.
A woman who has been diagnosed with lobular carcinoma in situ has a higher risk of developing invasive breast cancer later on. Other risk factors for developing breast cancer include a woman’s age, a family history of breast cancer, radiation exposure, and various hormonal factors. Regularly checking the breasts for any unusual lumps, nipple discharge, or changes in the skin increases a woman’s chance of detecting any type of cancer in its early stages.
Receiving treatment for lobular carcinoma in situ will depend on each individual situation. Sometimes a doctor will not recommend treatment for this condition since it is a precancerous condition. Instead, the doctor will advise the patient to undergo clinical screening on a regular basis so that any early signs of invasive breast cancer can be detected and treated. The benefits of cancer treatment will be weighed and weighed against the risk of the treatment in question. Treatment may be sought to increase a patient’s chance of recovery and prolong their survival.
Protect your devices with Threat Protection by NordVPN
